Australia markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.23+0.60 (+7.86%)
At close: 04:00PM EDT
8.22 -0.01 (-0.12%)
After hours: 06:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.12B
Enterprise value -279.87M
Trailing P/E 5.92
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)27.95
Price/book (mrq)0.70
Enterprise value/revenue -7.09
Enterprise value/EBITDA 0.42

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-67.29%
S&P500 52-week change 322.36%
52-week high 327.48
52-week low 37.61
50-day moving average 39.94
200-day moving average 310.53

Share statistics

Avg vol (3-month) 31.06M
Avg vol (10-day) 3897.71k
Shares outstanding 5135.84M
Implied shares outstanding 6135.84M
Float 889.34M
% held by insiders 114.14%
% held by institutions 175.83%
Shares short (15 Apr 2024) 45.15M
Short ratio (15 Apr 2024) 45.93
Short % of float (15 Apr 2024) 46.20%
Short % of shares outstanding (15 Apr 2024) 43.79%
Shares short (prior month 15 Mar 2024) 45.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-724.57%

Management effectiveness

Return on assets (ttm)-17.48%
Return on equity (ttm)-33.54%

Income statement

Revenue (ttm)86.18M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)-66.00%
Gross profit (ttm)N/A
EBITDA -640.57M
Net income avi to common (ttm)-615.06M
Diluted EPS (ttm)-4.59
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.52B
Total cash per share (mrq)11.27
Total debt (mrq)124.54M
Total debt/equity (mrq)7.83%
Current ratio (mrq)9.06
Book value per share (mrq)11.80

Cash flow statement

Operating cash flow (ttm)-778.79M
Levered free cash flow (ttm)-596.45M